S. Gundersen

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma

Wenche Reed, Einar Hannisdal, Per Johannes Boehler et al. · Cancer · 2000 · 137 citations

Medicine, Oncology, Surgery +17

The EORTC early clinical trials cooperative group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

R Abele, M. Clavel, P. Dodion et al. · European Journal of Cancer and Clinical Oncology · 1987 · 118 citations

Medicine, Oncology, Chemotherapy +7

Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.

Ragnar Hultborn, S. Gundersen, S. Rydén et al. · PubMed · 2000 · 117 citations

Medicine, Oncology, Surgery +17

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study

Seppo Pyrhönen, Ritva Valavaara, Hans Modig et al. · British Journal of Cancer · 1997 · 98 citations · Full text

Medicine, Oncology, Pharmacology +16